Calcium Channel Blockers

"Calcium Channel Blockers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A class of drugs that act by selective inhibition of calcium influx through cellular membranes.

Descriptor ID	D002121
MeSH Number(s)	D27.505.519.562.249 D27.505.954.411.192
Concept/Terms	Calcium Channel Blockers Calcium Channel Blockers Blockers, Calcium Channel Channel Blockers, Calcium Calcium Channel Antagonists Antagonists, Calcium Channel Calcium Channel Blocking Drugs Calcium Antagonists, Exogenous Calcium Antagonists, Exogenous Antagonists, Exogenous Calcium Exogenous Calcium Inhibitors Exogenous Calcium Antagonists Exogenous Calcium Blockaders Calcium Blockaders, Exogenous Calcium Inhibitors, Exogenous

Below are MeSH descriptors whose meaning is more general than "Calcium Channel Blockers".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Membrane Transport Modulators [D27.505.519.562]
Calcium Channel Blockers [D27.505.519.562.249]
Therapeutic Uses [D27.505.954]
Cardiovascular Agents [D27.505.954.411]
Calcium Channel Blockers [D27.505.954.411.192]

Below are MeSH descriptors whose meaning is more specific than "Calcium Channel Blockers".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Calcium Channel Blockers" by people in this website by year, and whether "Calcium Channel Blockers" was a major or minor topic of these publications.

Bar chart showing 27 publications over 15 distinct years, with a maximum of 5 publications in 1997

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	1	2	3
1995	1	1	2
1997	2	3	5
1998	0	1	1
1999	1	1	2
2000	0	1	1
2001	0	1	1
2002	1	0	1
2003	3	0	3
2004	0	1	1
2006	1	1	2
2008	2	0	2
2014	0	1	1
2016	0	1	1
2017	0	1	1

Below are the most recent publications written about "Calcium Channel Blockers" by people in Profiles.

Wang SV, Li N, Rice DS, Grosskreutz CL, Dryja TP, Prasanna G, Lii J, Gagne JJ. Using Healthcare Databases to Refine Understanding of Exploratory Associations Between Drugs and Progression of Open-Angle Glaucoma. Clin Pharmacol Ther. 2019 10; 106(4):874-883.

View in: PubMed
Johnson KP, Tran SM, Siegrist EA, Paidimarri KB, Elson MS, Berkowitz A. Turtle Flexion Reflex Motor Patterns Show Windup, Mediated Partly by L-type Calcium Channels. Front Neural Circuits. 2017; 11:83.

View in: PubMed
Harris JR, Hale GM, Dasari TW, Schwier NC. Pharmacotherapy of Vasospastic Angina. J Cardiovasc Pharmacol Ther. 2016 09; 21(5):439-51.

View in: PubMed
Iwuchukwu I, Ardelt A, Cueva W, Reshi R, Goldenberg F, Frank J. Macroglossia associated with brainstem injury. Neurocrit Care. 2014 Feb; 20(1):106-10.

View in: PubMed
Schaeffer S, Badillo RB. Poison control therapy. Am J Nurs. 2009 Dec; 109(12):42-5.

View in: PubMed
Sontheimer RD, Henderson CL, Grau RH. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation. Arch Dermatol Res. 2009 Jan; 301(1):65-70.

View in: PubMed
Cowley BD. Calcium, cyclic AMP, and MAP kinases: dysregulation in polycystic kidney disease. Kidney Int. 2008 Feb; 73(3):251-3.

View in: PubMed
Gosmanov AR, Connelly S, Lewis JB, Gosmanov NR. Antihypertensive medications and the risk of incident type 2 diabetes: response to Taylor et al. Diabetes Care. 2006 Oct; 29(10):2334; author reply 2334-5.

View in: PubMed
Leenen FH, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson LM, Alderman MH, Atlas SA, Basile JN, Cuyjet AB, Dart R, Felicetta JV, Grimm RH, Haywood LJ, Jafri SZ, Proschan MA, Thadani U, Whelton PK, Wright JT. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2006 Sep; 48(3):374-84.

View in: PubMed
Orsay C, Rakinic J, Perry WB, Hyman N, Buie D, Cataldo P, Newstead G, Dunn G, Rafferty J, Ellis CN, Shellito P, Gregorcyk S, Ternent C, Kilkenny J, Tjandra J, Ko C, Whiteford M, Nelson R. Practice parameters for the management of anal fissures (revised). Dis Colon Rectum. 2004 Dec; 47(12):2003-7.

View in: PubMed

People

Explore

Similar Concepts

Top Journals